Topical steroids for nasal polyps

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 4, 2016, Pages

  Kalish, Larry ^a,b   Snidvongs, Kornkiat ^c   Sivasubramaniam, Rahuram ^d   Cope, Daron ^b   Harvey, Richard J ^e  

^a Sydney Sinus and Allergy Centre   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d CANBERRA HOSPITAL   (Australia)

^e MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; GLUCOCORTICOID;

NOSE POLYP; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; CHRONIC DISEASE; COMPLICATION; HUMAN; INTRANASAL DRUG ADMINISTRATION; META ANALYSIS; NASAL POLYPS; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHINITIS; SINUSITIS;

ADMINISTRATION, INTRANASAL; CHRONIC DISEASE; GLUCOCORTICOIDS; HUMANS; NASAL POLYPS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHINITIS; SINUSITIS; STEROIDS;

EID: 84964659887     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006549.pub3     Document Type: Review

References (142)

1. Aukema AAC, Mulder PGH, Fokkens WJ. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. Journal of Allergy and Clinical Immunology 2005;115:1017-23.
2. Bross-Soriano D, Arrieta-Gomez JR, Prado-Calleros H. Infections after endoscopic polypectomy using nasal steroids. Otolaryngology - Head and Neck Surgery 2004;130(3):319-22.
3. Chalton R, Mackay I, Wilson R, Cole P. Double blind, placebo controlled trial of betamethasone nasal drops for nasal polyposis. British Medical Journal 1985;291:788.
4. Chalton R, Mackay IS, Wilson R, Cole P. A double-blind, placebo controlled trial of betamethasone nasal drops in the treatment of nasal polyposis. Clinical Otolaryngology 1986;11:389.
5. Chur V, Small CB, Stryszak P, Teper A. Mometasone furoate nasal spray is safe for the treatment of nasal polyps in pediatric subjects 6-17 years of age. Journal of Allergy & Clinical Immunology 2010;25(2 Suppl 2):AB101.
6. Dijkstra MD, Ebbens FA, Poublon RM, Fokkens WJ. Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery. Clinical and Experimental Allergy 2004;34(9):1395-400.
7. Dijkstra MD, Poublon RML, Fokkens WJ. The role of topical steroids after functional endoscopic sinus surgery for chronic sinusitis and/or nasal polyps. Clinical Otolaryngology and Allied Sciences 2001;26(4):341-2.
8. Dingsor G, Kramer J, Olsholt R, Soderstrom T. Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized, double blind, parallel, placebo controlled study. Rhinology 1985;23(1):49.
9. Drettner B, Ebbesen A, Nilsson M. Prophylactive treatment with flunisolide after polypectomy. Rhinology 1982;20(3):149-58.
10. Ehnhage A, Olsson P, Kölbeck KG, Skedinger M, Dahlén B, Alenius M, et al. Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis. Allergy: European Journal of Allergy and Clinical Immunology 2009;64(5):762-9.
11. El NM, Kale S, Aldren C, Martin F. Effect of Beconase nasal spray on olfactory function in post-nasal polypectomy patients: a prospective controlled trial. Journal of Laryngology and Otology 1995;109(10):941-4.
12. Filiaci F, Passali D, Puxeddu R, Schrewelius C. A randomized controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis. Rhinology 2000;38(4):185-90.
13. Hartwig S, Linden M, Laurent C, Vargo A-K, Lindqvist N. Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial). Journal of Laryngology and Otology 1988;102(2):148-51.
14. Holmberg K, Juliusson S, Balder B, Smith DL, Richards DH, Karlsson G. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Annals of Allergy, Asthma and Immunology 1997;78(3):270-6.
15. Holmström M. Clinical performance of fluticasone propionate nasal drops. Allergy: European Journal of Allergy and Clinical Immunology 1999;54(Suppl 53):21-5.
16. Holopainen E, Grahne B, Malmberg H. Budesonide in the treatment of nasal polyposis. European Journal of Respiratory Diseases 1982;63(Suppl 122):221-8.
17. Jankowski R, Schrewelius C, Bonfils P, Saban Y, Gilain L, Prades JM, et al. Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps. Archives of Otolaryngology -- Head and Neck Surgery 2001;127:447-52.
18. Jankowski R, Klossek JM, Attali V, Coste A, Serrano E. Long-term study of fluticasone propionate aqueous nasal spray in acute and maintenance therapy of nasal polyposis. Allergy 2009;64(6):944-50.
19. Vendelo Johansen L, Illum P, Kristensen S, Winther L, Vang Petersen S, Synnerstad B. The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps. Clinical Otolaryngology & Allied Sciences 1993;18(6):524-7.
20. Johansson L, Holmberg K, Melen I, Stierna P, Bende M. Sensitivity of a new grading system for studying nasal polyps with the potential to detect early changes in polyp size after treatment with a topical corticosteroid (budesonide). Acta Oto-Laryngologica 2002;122(1):49-53.
21. Jorissen M, Bechert C. Effect of steroids on wound healing after endoscopic sinus surgery. Rhinology 2009;47(3):280-6.
22. Jurkiewicz D, Zielnik-Jurkiewicz B, Wojdas A. Effectiveness of fluticasone propionate in nasal polyps treatment. International Review of Allergology and Clinical Immunology 2004;10(1):22-4.
23. Karlsson G, Rundcrantz H. A randomized trial in intranasal beclomethasone dipropionate after polypectomy. Rhinology 1982;20(3):144-8.
24. Keith P, Nieminen J, Hollingworth K, Dolovich J. Efficacy and tolerability of fluticasone propionate nasal drops 400 mug daily compared with placebo for the treatment of bilateral polyposis in adults. Clinical and Experimental Allergy 2000;30(10):1460-8.
25. Land DA, McNeill J. Double blind controlled study of effect of topical steroids on nasal polyps. Clinical Otolaryngology 1983;8:139.
26. Lildholdt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clinical Otolaryngology and Allied Sciences 1995;20(1):26-30.
27. Lund VJ, Flood J, Sykes AP, Richards DH. Effect of fluticasone in severe polyposis. Archives of Otolaryngology -- Head and Neck Surgery 1998;124(5):513-8.
28. Mastalerz L, Milewski M, Duplaga M, Nizankowska E, Szczeklik A. Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma. Allergy 1997;52(9):895-900.
29. Mygind N, Pedersen CB, Prytz S, Sorensen H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clinical Allergy 1975;5(2):159-64.
30. Olsson P, Ehnhage A, Nordin S, Stjarne P. Quality of life is improved by endoscopic surgery and fluticasone in nasal polyposis with asthma. Rhinology 2010;48(3):325-30.
31. Passali D, Bernstein JM, Passali FM, Damiani V, Passali GC, Bellussi L. Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis. Archives of Otolaryngology -- Head and Neck Surgery 2003;129(6):656-9.
32. Penttila M, Holstrom M, Poulsen P, Hollingworth K. The efficacy and tolerability of fluticasone propionate (FP) nasal drops 400fig once daily and twice daily compared with placebo in the treatment of nasal polyposis. Allergy 1998;53(Suppl 43):109.
33. Penttila M, Poulsen P, Hollingworth K, Holmstrom M. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients. Clinical and Experimental Allergy 2000;30(1):94-102.
34. Rotenberg BW, Zhang I, Arra I, Payton KB. Postoperative care for Samter's triad patients undergoing endoscopic sinus surgery: a double-blinded, randomized controlled trial. Laryngoscope 2011;121:2702-5.
35. Rowe-Jones JM, Medcalf M, Durham SR, Richards DH, Mackay IS. Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology 2005;43(1):2-10.
36. Ruhno J, Andersson B, Denburg J, Anderson M, Hitch D, Lapp P, et al. A double-blind comparison of intranasal budesonide with placebo for nasal polyposis. Journal of Allergy and Clinical Immunology 1990;86:946-53.
37. Small CB, Hernandez J, Reyes A, Schenkel E, Damiano A, Stryszak P, et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. Journal of Allergy and Clinical Immunology 2005;116(6):1275-81.
38. Small CB, Stryszak P, Danzig M, Damiano A. Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis. Journal of Allergy and Clinical Immunology 2008;121(4):928-32.
39. Stjarne P, Mosges R, Jorissen M, Passali D, Bellussi L, Staudinger H, et al. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Archives of Otolaryngology -- Head and Neck Surgery 2006;132:179-85.
40. Stjarne P, Blomgren K, Caye-Thomasen P, Salo S, Soderstrom T. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. Acta Oto-Laryngologica 2006;126(6):606-12.
41. Stjarne P, Olsson P, Alenius M. Use of mometasone furoate to prevent polyp relapse after endoscopic sinus surgery. Archives of Otolaryngology -- Head and Neck Surgery 2009;135(3):296-302.
42. Tos M, Svendstrup F, Arndal H, Orntoft S, Jakobsen J, Borum P, et al. Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps. American Journal of Rhinology 1998;12(3):183-9.
43. Vento SI, Blomgren K, Hytonen M, Simola M, Malmberg H. Prevention of relapses of nasal polyposis with intranasal triamcinolone acetonide after polyp surgery: a prospective double-blind, placebo-controlled, randomised study with a9-month follow-up. Clinical Otolaryngology 2012;37:117-23.
44. Vlckova I, Navrátil P, Kana R, Pavlicek P, Chrbolka P, Djupesland PG. Effective treatment of mild-to-moderate nasal polyposis with fluticasone delivered by a novel device. Rhinology 2009;47(4):419-26.
45. Albu S, Gocea A, Mitre I. Preoperative treatment with topical corticoids and bleeding during primary endoscopic sinus surgery. Otolaryngology - Head and Neck Surgery 2010;143:573-8.
46. Alobid I, Benítez P, Bernal-Sprekelsen M, Roca J, Alonso J, Picado C, et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy 2005;60(4):452-8.
47. Alobid I, Benítez P, Bartra J, Munoz R, Valero A, Picado C, et al. Steroid treatment improve nasal patency and paradoxically increase nasal nitric oxide in patients with severe nasal polyposis. Allergy: European Journal of Allergy and Clinical Immunology 2011;66:246-7.
48. Bavbek S, Dursun AB, Dursun E, Eryilmaz A, Misirligil Z. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study. International Archives of Allergy and Immunology 2007;142(1):64-9.
49. Benitez P, Alobid I, Haro J, Berenguer J, Bernal-Sprekelsen, Pujols L, et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope 2006;116(5):770-5.
50. Blomqvist EH, Lundblad L, Anggard A, Haraldsson P-O, Stjarne P. A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. Journal of Allergy and Clinical Immunology 2001;107(2):224-8.
51. Castro M, Mathur S, Hargreave F, Boulet LP, Xie F, Young J, et al. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. American Journal of Respiratory and Critical Care Medicine 2011;184:1125-32.
52. Chen F, Huang W, Qiao L, Jiang H, Qiu J. The expression of transforming growth factor alpha, beta 1 in hyperplastic tissue after endoscopic polypectomy and the effect of corticosteroid. Lin Chuang Bi Yan Hou Ke Za Zhi 2002;16:399-401.
53. Corradini C, Del Ninno M, Buonomo A, Nucera E, Paludetti G, Alonzi C, et al. Amphotericin B and lysine acetylsalicylate in the combined treatment of nasal polyposis associated with mycotic infection. Journal of Investigational Allergology and Clinical Immunology 2006;16(3):188-93.
54. Demirel T, Orhan KS, Keles N, Deger K. Comparison of the efficacy of nasal drop and nasal spray applications of fluticasone propionate in nasal polyps. Kulak Burun Bogaz Ihtis Derg 2008;18:1-6.
55. Deuschl H, Drettner B. Nasal polyps treated by beclomethasone nasal aerosol. Rhinology 1977;15(1):17-23.
56. Caritas St. Elizabeth's Medical Center of Boston. Treatment of early nasal polyposis with topical triamcinolone. http://clinicaltrials.gov/ct2/show/NCT01222871. [NCT01222871]
57. Enomoto T, Nagasako-Akazome Y, Kanda T, Ikeda M, Dake Y. Clinical effects of apple polyphenols on persistent allergic rhinitis: a randomized double-blind placebo-controlled parallel arm study. Journal of Investigational Allergology and Clinical Immunology 2006;16(5):283-9.
58. Fokkens WJ, Rinia B, Van Drunen CM, Hellings PW, Hens G, Jansen A, et al. No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray. American Journal of Rhinology and Allergy 2012;26:36-44.
59. Fowler PD, Gazis AG, Page SR, Jones NS. A randomized double-blind study to compare the effects of nasal fluticasone and betamethasone on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis. Clinical Otolaryngology and Allied Sciences 2002;27(6):489-93.
60. Graham SM, Scott SN, Launspach J, Zabner J. The effects of fluticasone propionate on nasal epithelial potential difference. American Journal of Rhinology 2002;16(3):145-9.
61. Grater WC, Brandon M, Brown EB, Finke S, Knight A, Lanoff G, et al. A double-blind labeled study of dexamethasone nasal aerosol vs. placebo in the treatment of nasal polyposis. Journal of Allergy 1968;41:10-3.
62. Guilan University of Medical Sciences. Effects of intranasal amphotericin-B irrigation on recurrence of massive nasal polyposis after endoscopic sinus surgery and comparison with nasal corticosteroid sprays. http://www.irct.ir/searchresult.php?id=1138&number=1.
63. Hadfield PJ, Rowe-Jones JM, Mackay IS. A prospective treatment trial of nasal polyps in adults with cystic fibrosis. Rhinology 2000;38(2):63-5.
64. Hansen FS, Djupesland PG, Fokkens WJ. Preliminary efficacy of fluticasone delivered by a novel device in recalcitrant chronic rhinosinusitis. Rhinology 2010;48(3):292-9.
65. Henriksson G, Norlander T, Forsgren J, Stierna P. Effects of topical budesonide treatment on glucocorticoid receptor mRNA down-regulation and cytokine patterns in nasal polyps. American Journal of Rhinology 2001;15(1):1-8.
66. Hissaria P, Smith W, Wormald PJ, Taylor J, Vadas M, Gillis D, et al. Short course of systemic steroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. Journal of Allergy and Clinical Immunology 2006;118(1):128-33.
67. Institute LHR. A comparison of beclomethasone aqueous spray and aerosol delivery systems in nasal polyps. http://clinicaltrials.gov/ct2/show/NCT00788463. [NCT00788463]
68. Irifune M, Ogino S, Harada T, Abe Y. Topical treatment of nasal polyps with a beclomethasone dipropionate powder preparation. Auris, Nasus, Larynx 1999;26(1):49-55.
69. Jiang YM, Jiang XC, Li JP, Zhang C, Wang JD. Influence of nebulized Pulmicort respules inhalation after endoscopic sinus surgery on expression of ENaC protein. Journal of Shanghai Jiaotong University (Medical Science) 2010;30(1):80-3.
70. Jurkiewicz D, Rapiejko P. Use of isotonic NaCl solution in patients with acute rhinosinusitis. Otolaryngologia Polska 2011;65:47-53.
71. Kim YH, Jung G, Lee SJ, Ko BY, Jang TY. Outcomes of middle meatal antrostomy after different surgical strategies. Acta Oto-Laryngologica 2011;9:1002-7.
72. Kroflic B, Baudoin T, Kalogjera L. Topical furosemide versus oral steroid in preoperative management of nasal polyposis. European Archives of Oto-Rhino-Laryngology 2006;263(8):767-71.
73. Kurent Z, Zargi M. Endoscopic polypectomy vs. endoscopic ethmoidectomy in combined treatment of massive bilateral nasal polyposis. ERS & ISIAN Meeting 1998. 1998:187-90.
74. Landsberg R, Segev Y, DeRowe A, Landau T, Khafif A, Fliss DM. Systemic steroids for allergic fungal rhinosinusitis and chronic rhinosinusitis with nasal polyposis: a comparative study. Otolaryngology - Head and Neck Surgery 2007;136(2):252-7.
75. Li C, Zhao Y, Liang C, An H. Observations of the curative effect with various liquid for post operative irrigation of ESS of treating chronic sinusitis and nasal polyps. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2001;15:53-4.
76. Lildholdt T, Fogstrup J, Gammelgaard N, Kortholm B, Ulsoe C. Surgical versus medical treatment of nasal polyps. Acta Oto-Laryngologica 1988;105(1-2):140-3.
77. Lildholdt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Archives of Otolaryngology -- Head and Neck Surgery 1997;123(6):595-600.
78. Lundblad L, Sipila P, Farstad T, Drozdziewicz D. Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a Nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Oto-Laryngologica 2001;121(4):505-9.
79. Malerba M, Radaeli A, Ceriani L, Massimo Amato M, Tomenzoli D, Nicolai P, et al. Comparison of oral montelukast and inhaled fluticasone in the treatment of asthma associated with chronic rhinopolyposis: a single-blind, randomized, pilot study. Current Therapeutic Research, Clinical and Experimental 2002;63(6):355-65.
80. Manssor BP. Simple (massive) nasal polyps - difficult to treat. Biomedica 1997;13(2):73-84.
81. Martínez-Antón A, de Bolós C, Alobid I, Benítez P, Roca-Ferrer J, Picado C, et al. Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps. Allergy: European Journal of Allergy and Clinical Immunology 2008;63(10):1368-76.
82. Massachusetts General Hospital. Subcutaneous omalizumab for treatment of chronic rhinosinusitis with nasal polyposis. http://clinicaltrials.gov/ct2/show/NCT01066104. [NCT01066104]
83. Mastruzzo C, Greco LR, Nakano K, Nakano A, Palermo F, Pistorio MP, et al. Impact of intranasal budesonide on immune inflammatory responses and epithelial remodeling in chronic upper airway inflammation. Journal of Allergy and Clinical Immunology 2003;112(1):37-44.
84. Maune S, Johannssen V, Sahly H, Werner JA, Salhy H. Prospective randomized investigation for evaluation of postoperative changes in the microbial climate of paranasal mucosa by the use of different dissoluting techniques during postoperative care. Rhinology 1999;37(3):113-6.
85. Mostafa BE. Fluticasone propionate is associated with severe infection after endoscopic polypectomy. Archives of Otolaryngology -- Head and Neck Surgery 1996;122(7):729-31.
86. Mostafa BE, Abdel Hay H, Mohammed HE, Yamani M. Role of leukotriene inhibitors in the postoperative management of nasal polyps. ORL; Journal of Oto-Rhino-Laryngology and Its Related Specialties 2005;67(3):148-53.
87. Pujols L, Alobid I, Benítez P, Martínez-Antón A, Roca-Ferrer J, Fokkens WJ, et al. Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids. Allergy 2008;63(10):1377-86.
88. Pujols L, Benítez P, Alobid I, Martinez-Anton A, Roca-Ferrer J, Mullol J, et al. Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo. European Respiratory Journal 2009;33(3):502-8.
89. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004;114(5):923-30.
90. Ragab SM, Lund VJ, Saleh HA, Scadding G. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. Allergy 2006;61(6):717-24.
91. Ragab SM, Lund VJ, Scadding G, Saleh HA, Khalifa MA. Impact of chronic rhinosinusitis therapy on quality of life; a prospective randomized controlled trial. Rhinology 2010;48(3):305-11.
92. Ragad S, Scadding GK, Lund VJ, Saleh H. Treatment of chronic rhinosinusitis and its effects on asthma. European Respiratory Journal 2006;28(1):68-74.
93. Raghavan U, Jones NS. A prospective randomized blinded cross-over trial using nasal drops in patients with nasal polyposis: an evaluation of effectiveness and comfort level of two head positions. American Journal of Rhinology 2006;20(4):397-400.
94. Sagit M, Erdamar H, Saka C, Yalcin S, Akin I. Effect of antioxidants on the clinical outcome of patients with nasal polyposis. Journal of Laryngology and Otology 2011;125:811-5.
95. Saunders MW, Wheatley AH, George SJ, Lai T, Birchall MA. Do steroids induce apoptosis in nasal polyp inflammatory cells? In vivo and in vitro studies. Laryngoscope 1999;109(5):785-90.
96. Schering-Plough Study of Nasonex for the treatment of nasal polyps in pediatric subjects between the ages of 6 and less than 18 years old. http://ClinicalTrials.gov/show/NCT00378378. [NCT00378378]
97. Selivanova O, Kuehnemund M, Mann WJ, Amedee RG. Comparison of conventional instruments and mechanical debriders for surgery of patients with chronic sinusitis. American Journal of Rhinology 2003;17(4):197-202.
98. Services RaI. A proof of concept study to investigate the clinical, histological and molecular predictors of response to oral and intranasal corticosteroid in nasal polyposis - prednisolone induction. https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2004-001474-12.
99. Shi G, He M, Liu Y, Li X. Observation of the effect of BCG-SPN in FESS perioperative period. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005;19:67-8.
100. Sieskiewicz A, Olszewska E, Rogowski M, Grycz E. Preoperative corticosteroid oral therapy and intraoperative bleeding during functional endoscopic sinus surgery in patients with severe nasal polyposis: a preliminary investigation. Annals of Otology, Rhinology and Laryngology 2006;115(7):490-4.
101. Stevenson DD, Mehra PK, White AA, Gupta S, Woessner KM, Simon RA. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease. Journal of Allergy and Clinical Immunology 2005;116(4):755-60.
102. Stewart RA, Ram B, Hamilton G, Weiner J, Kane KJ. Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis. Otolaryngology - Head and Neck Surgery 2008;139(5):682-7.
103. Taub SJ. Dexamethasone nasal aerosol vs placebo in treatment of nasal polyposis. Eye, Ear, Nose and Throat Monthly 1968;47:392.
104. Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, et al. Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. BMC Pulmonary Medicine 2011;11:11-8.
105. Toft A, Wihl JA, Toxman J, Mygind N. Double-blind comparison between beclomethasone dipropionate as aerosol and as powder in patients with nasal polyposis. Clinical Allergy 1982;12(4):391-401.
106. Vaidyanathan S, Barnes M, Williamson P, Hopkinson P, Donnan PT, Lipworth B. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial. Annals of Internal Medicine 2011;154:293-302.
107. Valera FC, Queiroz R, Scrideli C, Tone LG, Anselmo-Lima WT. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment. Clinical and Experimental Allergy 2009;39(1):81-8.
108. Van Gerven L, Jorissen M, Fokkens W, Hellings P. Montelukast as add-on treatment to intranasal steroids does not show a major clinical efficacy in nasal polyps. Allergy: European Journal of Allergy and Clinical Immunology 2011;66:22-3.
109. Van Zele T, Gevaert P, Holtappels G. Treatment of nasal polyposis with oral methylprednisolone: a double-blind, randomized, placebo-controlled trial with evaluation of clinical and biological activity. Journal of Allergy and Clinical Immunology 2008;121(2 (Suppl 1)):S265.
110. Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. Journal of Allergy and Clinical Immunology 2010;125(5):1069-76.e4.
111. Vuralkan E, Saka C, Akin I, Hucumenoglu S, Unal BU, Kuran G, et al. Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps. Therapeutic Advances in Respiratory Disease 2011;6:5-10.
112. Wadwongtham W, Aeumjaturapat S. Large middle meatal antrostomy vs undisturbed maxillary ostium in the endoscopic sinus surgery of nasal polyposis. Journal of the Medical Association of Thailand 2003;86(Suppl 2):S373-8.
113. Wang J, Yang B. Effects of dexamethasone on mucin gene expression in human nasal polyps. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2004;18:74-6.
114. Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system. Laryngoscope 2007;117(11 Pt 2 Suppl 115):1-28.
115. Zeng M, Long XB, Cui YH, Liu Z. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults. American Journal of Rhinology and Allergy 2011;25:e203-e7.
116. Zheng C, Wang Z, Lacroix JS. Effect of intranasal treatment with capsaicin on the recurrence of polyps after polypectomy and ethmoidectomy. Acta Oto-Laryngologica 2000;120(1):62-6.
117. OptiNose UK Ltd. A double blind, randomised, parallel group, placebo-controlled study to investigate the efficacy and tolerability of intranasal fluticasone propionate delivered by the OptiNose device in adult patients with bilateral nasal polyposis. https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006340-60/CZ.
118. Bachert C, Watelet JB, Gevaert P, Van Cauwenberge P. Pharmacological management of nasal polyposis. Drugs 2005;65(11):1537-52.
119. Bachert C, Zhang N, Patou J, van Zele T, Gevaert P. Role of staphylococcal superantigens in upper airway disease. Current Opinion in Allergy and Clinical Immunology 2008;8:34-8.
120. Badia L, Lund V. Topical steroids in nasal polyposis. Drugs 2001;61(5):573-8.
121. Bateman ND, Fahy C, Woolford TJ. Nasal polyps: still more questions than answers. Journal of Laryngology and Otology 2003;117(1):1-9.
122. Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngology - Head and Neck Surgery 2003;129(3 Suppl):S1-32.
123. Chong LY, Head K, Hopkins C, Philpott C, Schilder AGM, Burton MJ. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database of Systematic Reviews 2016, Issue 4. [DOI: 10.1002/14651858.CD011996.pub2]
124. Chong LY, Head K, Hopkins C, Philpott C, Burton MJ, Schilder AGM. Different types of intranasal steroids for chronic rhinosinusitis. Cochrane Database of Systematic Reviews 2016, Issue 4. [DOI: 10.1002/14651858.CD011993.pub2]
125. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
126. FDA Center for Drug Evaluation and Research (CDER). Safety information. http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm122996.htm 2008.
127. Fokkens W, Lund V, Mullol J, European Position Paper on Rhinosinusitis and Nasal Polyps Group. European Position Paper on Nasal Polyps 2007. Rhinology 2007;45(Suppl 20):1-136.
128. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
129. Hellquist HB. Nasal polyps update. Histopathology. Allergy and Asthma Proceedings 1996;17(5):237-42.
130. Joe SA, Thambi R, Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngology - Head and Neck Surgery 2008;139:340-7.
131. Klossek JM, Neukirch F, Pribil C, Jankowski R, Serrano E, Chanal I, et al. Prevalence of nasal polyposis in France: a cross-sectional, case-control study. Allergy 2005;60(2):233-7.
132. Lanier B, Kai G, Marple B, Wall GM. Pathophysiology and progression of nasal septal perforation. Annals of Allergy, Asthma, and Immunology 2007;99(6):473-9.
133. Lund VJ, Kennedy DW. Quantification for staging sinusitis. Annals of Otology, Rhinology, and Laryngology. Supplement 1995;167(104):17-21.
134. Martinez-Devesa P, Patiar S. Oral steroids for nasal polyps. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD005232.pub3]
135. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngology - Head and Neck Surgery 2004;131(6 Suppl):S1-S62.
136. Meltzer EO. Formulation considerations of intranasal steroids for the treatment of allergic rhinitis. Annals of Allergy, Asthma, and Immunology 2007;98(1):12-21.
137. Mladina R, Clement P, Lopatin A, Mann W, Passali D. International Consensus on Nasal Polyposis 2002-2004. European Archives of Oto-Rhino-Laryngology 2005;262(6):519-21.
138. Mygind ND, Bachert RC. Nasal polyposis, eosinophil dominated inflammation, and allergy. Thorax 2000;55(Suppl 2):79-83.
139. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
140. Scadding GK. Comparison of medical and surgical treatment of nasal polyposis. Current Allergy and Asthma Reports 2002;2(6):494-9.
141. Slavin RG. Nasal polyps and sinusitis. Clinical Allergy and Immunology 2002;16:295-309.
142. Snidvongs K, Kalish L, Sacks R, Craig JC, Harvey RJ. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD009274]